Hematología y Hemoterapia

Resultados: 409
Tipo Título / Nombre Autor(es) Año
Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies? Sánchez-Correa B, Campos C, Pera A, Bergua JM, Arcos MJ, Bañas H, et al 2016
Seguridad Transfusional y efectos adversos: protocolos y actuaciones Ibáñez Espacio F, Lanzas Merino F 2015
Seguridad transfusional y efectos adversos Ibáñez Espacio F, Lanzas Merino 2015
Púrpura Trombótica Trombocitopénica Ibáñez Espacio F 2015
Usefulness of Eltrombopag in Secondary ITP Patients in Clinical Practice Gonzalez Lopez TJ, Alvarez Roman MT, Pascual C, Sanchez Gonzalez B, Fernandez Fuentes F, Bermejo N [et al.] 2015
Bortezomib Plus Melphalan and Prednisone (VMP) Followed By Lenalidomide and Dexamethasone (Rd) in Newly Diagnosed Elderly Myeloma Patients Overcome the Poor Prognosis of High-Risk Cytogenetic Abnormalities (CA) Detected By Fluorescence in Situ Hibridizati Mateos MV, Gutierrez NC, Martín ML, Martínez López J, Hernández MT, Martínez R, et al 2015
High Correlation Clinical Responses to 1st Line Acute Myeloid Leukemia Treatment with an Ex Vivo Native Environment Precision Medicine Test Montesinos P, Ballesteros J, Martinez Cuadrón D, Martínez López J, Serrano J, Pérez de Oteyza J, et al 2015
Assessment of Clinical Differences Between Starting Antimyeloma Treatment at Biological Relapse or at Clinical Relapse: Preliminary Results of an Observational Prospective Registry Gironella M, Bergua J, Fernández de Larrea C, Escalante F, González M, Martínez Chamorro C, et al 2015
Post-Remission Treatment with Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-neg) Adult Acute Lymphoblastic Leukemia (ALL) According to Minimal Residual Disease (MRD). P Ribera JM, Morgades M, Ciudad J, Barba P, Martino R, Montesinos P, et al 2015
Incidence, Treatment and Prognosis of Patients with Relapsed Burkitt Lymphoma/Leukemia Treated with Specific Chemotherapy or Immunochemotherapy in Spain Pineda A, Sancho JM, García O, Esteve J, Tormo M, Martínez P, et al 2015